Merck is acquiring the Yale-spinout, which develops direct DNA modification-enabled cancer treatments.
Merck Acquires Modifi Biosciences
Merck is acquiring the Yale-spinout, which develops direct DNA modification-enabled cancer treatments.
You may also like
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.